Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribonuclease (RNase) is a type of nuclease enzyme that catalyzes the degradation of RNA into smaller components by cleaving the phosphodiester bonds between nucleotides. RNases are found ubiquitously in all living organisms and play essential roles in RNA metabolism, including RNA maturation, degradation, turnover, and quality control. They are classified as endoribonucleases (cleave internal bonds) or exoribonucleases (remove nucleotides from ends), and further based on catalytic mechanism (phosphorolytic or hydrolytic). Examples include RNase A, RNase B, RNase III, RNase L, and RNase P. RNases are crucial for mRNA degradation, rRNA/tRNA processing, and gene expression regulation. They have applications in research for RNA removal during DNA purification and as model systems for protein folding studies.
Catalyzes the degradation of RNA by cleaving phosphodiester bonds.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribonuclease (RNase).